RE:RE:PHM DatabaseThe financials of the patient list are hard to figure out Gregory, but so far the 40% organic growth has been more than anyone expected. The biggest factor right now is that every patient acquired has been only receiving one service from the target company Phm is acquiring and most patients have at least two conditions that require a service. With such a high initial take-up and with the patient list quadrupling, as long as patients have received a service within a 15 month period from one of our companies, Phm can continue to mine that patient list for years to come. Regardless of what the company does financially, the patient list is extremely valuable. Think about how users of an app get valued just for their eyeballs, then compare that Phm's list of revenue generating patients that large companies can only contact if they own that patient list. Phm wins any way you look at it.